Birner Dental Management Services (BDMS) 10-Q 12 Nov 15 2015 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Nov. 03, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	BIRNER DENTAL MANAGEMENT SERVICES INC
Entity Central Index Key	948,072
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		1,861,106
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
CURRENT ASSETS:
Cash and cash equivalents	$ 314,889	$ 310,229
Accounts receivable, net of allowance for doubtful accounts of approximately $420,000 and $390,000, respectively	3,356,104	3,185,136
Notes receivable	34,195	34,195
Deferred tax asset	384,333	614,944
Prepaid expenses and other assets	656,173	520,187
Total current assets	4,745,694	4,664,691
PROPERTY AND EQUIPMENT, net	10,080,912	11,258,025
OTHER NONCURRENT ASSETS:
Intangible assets, net	7,776,789	8,410,535
Deferred charges and other assets	158,403	160,853
Notes receivable	62,141	82,929
Total assets	22,823,939	24,577,033
CURRENT LIABILITIES:
Accounts payable	2,786,929	2,912,162
Accrued expenses	1,478,557	1,557,811
Accrued payroll and related expenses	2,419,739	2,511,953
Income taxes payable	240,284	6,638
Current maturities of long-term debt	10,397,795	0
Total current liabilities	17,323,304	6,988,564
LONG-TERM LIABILITIES:
Deferred tax liability, net	2,147,109	2,951,321
Long-term debt	0	9,833,453
Other long-term obligations	981,802	1,046,633
Total liabilities	20,452,215	20,819,971
SHAREHOLDERS' EQUITY:
Preferred Stock, no par value, 10,000,000 shares authorized; none outstanding	0	0
Common Stock, no par value, 20,000,000 shares authorized; 1,859,689 and 1,861,106 shares issued and outstanding, respectively	1,386,427	1,214,056
Retained earnings	985,297	2,543,006
Total shareholders' equity	2,371,724	3,757,062
Total liabilities and shareholders' equity	$ 22,823,939	$ 24,577,033

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
CURRENT ASSETS:
Allowance for doubtful accounts	$ 390,000	$ 420,000
SHAREHOLDERS' EQUITY:
Preferred Stock, par value (in dollars per share)	$ 0	$ 0
Preferred Stock, authorized (in shares)	10,000,000	10,000,000
Preferred Stock, outstanding (in shares)	0	0
Common Stock, par value (in dollars per share)	$ 0	$ 0
Common Stock, authorized (in shares)	20,000,000	20,000,000
Common Stock, issued (in shares)	1,861,106	1,859,689
Common Stock, outstanding (in shares)	1,861,106	1,859,689

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended				9 Months Ended
	Sep. 30, 2015		Sep. 30, 2014		Sep. 30, 2015		Sep. 30, 2014
REVENUE:
Dental practice revenue	$ 14,681,849		$ 14,823,803		$ 45,241,736		$ 45,867,717
Capitation revenue	1,170,907		1,277,041		3,553,173		3,916,049
Total Revenue	15,852,756		16,100,844		48,794,909		49,783,766
DIRECT EXPENSES:
Clinical salaries and benefits	9,491,411		9,643,784		29,155,036		29,471,225
Dental supplies	762,736		776,431		2,261,936		2,230,122
Laboratory fees	851,678		797,007		2,516,851		2,493,786
Occupancy	1,514,141		1,511,804		4,426,666		4,429,726
Advertising and marketing	326,756		209,061		707,661		678,310
Depreciation and amortization	1,061,157		1,103,335		3,255,507		3,097,413
General and administrative	1,350,066		1,304,149		3,926,094		4,129,054
Total Direct Expenses	15,357,945		15,345,571		46,249,751		46,529,636
Contribution from dental offices	494,811		755,273		2,545,158		3,254,130
CORPORATE EXPENSES:
General and administrative	779,585	[1]	1,327,993	[1]	2,836,925	[2]	3,677,019	[2]
Depreciation and amortization	62,616		56,132		174,524		167,426
OPERATING LOSS	(347,390)		(628,852)		(466,291)		(590,315)
Interest expense, net	24,143		31,293		74,700		86,072
LOSS BEFORE INCOME TAXES	(371,533)		(660,145)		(540,991)		(676,387)
Income tax benefit	(144,897)		(257,457)		(210,986)		(263,791)
NET LOSS	$ (226,636)		$ (402,688)		$ (330,005)		$ (412,596)
Net loss per share of Common Stock - Basic (in dollars per share)	$ (0.12)		$ (0.22)		$ (0.18)		$ (0.22)
Net loss per share of Common Stock - Diluted (in dollars per share)	(0.12)		(0.22)		(0.18)		(0.22)
Cash dividends per share of Common Stock (in dollars per share)	$ 0.22		$ 0.22		$ 0.66		$ 0.66
Weighted average number of shares of Common Stock and dilutive securities:
Basic (in shares)	1,860,482		1,860,089		1,859,956		1,858,232
Diluted (in shares)	1,860,482		1,860,089		1,859,956		1,858,232
[1]	Corporate expense - general and administrative includes $62,765 of stock-based compensation expense pursuant to ASC Topic 718 and $338,861 of severance compensation expense for the quarter ended September 30, 2014 and $42,075 of stock-based compensation expense pursuant to ASC Topic 718 for the quarter ended September 30, 2015.
[2]	Corporate expense - general and administrative includes $232,800 of stock-based compensation expense pursuant to ASC Topic 718 and $338,861 of severance compensation expense for the nine months ended September 30, 2014 and $169,338 of stock-based compensation expense pursuant to ASC Topic 718 for the nine months ended September 30, 2015.

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parenthetical) - General and Administrative Expenses [Member] - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock based compensation expense	$ 42,075	$ 62,765	$ 169,338	$ 232,800
Severance compensation expense		$ 338,861		$ 338,861

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (UNAUDITED) - 9 months ended Sep. 30, 2015 - USD ($)	Common Stock [Member]	Retained Earnings [Member]	Total
BALANCES at Dec. 31, 2014	$ 1,214,056	$ 2,543,006	$ 3,757,062
BALANCES (in shares) at Dec. 31, 2014	1,859,689		1,859,689
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock options exercised	$ 7,671	0	$ 7,671
Common Stock options exercised (in shares)	1,417
Tax expense of Common Stock options exercised	$ (4,638)	0	(4,638)
Dividends declared on Common Stock	0	(1,227,704)	(1,227,704)
Stock-based compensation expense	169,338	0	169,338
Net loss	0	(330,005)	(330,005)
BALANCES at Sep. 30, 2015	$ 1,386,427	$ 985,297	$ 2,371,724
BALANCES (in shares) at Sep. 30, 2015	1,861,106		1,861,106

CONDENSED CONSOLIDATED STATEME7

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income/(loss)	$ (330,005)	$ (412,596)
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:
Depreciation and amortization	3,430,031	3,264,839
Stock-based compensation expense	169,338	232,800
Provision for doubtful accounts	568,820	688,789
Provision for (benefit from) deferred income taxes	(573,601)	(824,092)
Loss (gain) on sale of assets	(3,948)	9,220
Changes in assets and liabilities
Accounts receivable	(739,788)	(633,651)
Prepaid expenses and other assets	(135,986)	(200,889)
Deferred charges and other assets	2,450	3,933
Accounts payable	(125,233)	(546,203)
Accrued expenses	(79,564)	167,983
Accrued payroll and related expenses	(92,214)	530,386
Income taxes payable/(receivable)	233,646	716,755
Other long-term obligations	(64,831)	22,072
Net cash provided by operating activities	2,259,115	3,019,346
CASH FLOWS USED IN INVESTING ACTIVITIES:
Capital expenditures	(1,620,224)	(4,310,494)
Notes receivable	20,788	19,848
Proceeds from sale of assets	5,000	19,275
Net cash used in investing activities	(1,594,436)	(4,271,371)
CASH FLOWS USED IN FINANCING ACTIVITIES:
Advances - line of credit	21,420,373	21,608,633
Repayments - line of credit	(20,856,031)	(19,398,435)
Proceeds from exercise of Common Stock options	7,671	64,500
Tax benefit (expense) of Common Stock options exercised	(4,638)	11,211
Common Stock cash dividends	(1,227,394)	(1,226,004)
Net cash provided by (used in) financing activities	(660,019)	1,059,905
NET CHANGE IN CASH AND CASH EQUIVALENTS	4,660	(192,120)
CASH AND CASH EQUIVALENTS, beginning of period	310,229	469,827
CASH AND CASH EQUIVALENTS, end of period	314,889	277,707
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	109,890	97,028
Cash paid for income taxes	138,535	16,226
Cash received for income taxes	$ 4,929	$ 183,891

UNAUDITED CONDENSED CONSOLIDATE

UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS	9 Months Ended
	Sep. 30, 2015
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS [Abstract]
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS	(1) UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS The condensed consolidated financial statements included herein are unaudited and have been prepared by Birner Dental Management Services, Inc. (the “Company”) pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures included herein are adequate to make the information presented not misleading. A description of the Company’s accounting policies and other financial information is included in the audited consolidated financial statements as filed with the SEC in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of the Company as of September 30, 2015 and the results of operations and cash flows for the periods presented. All such adjustments are of a normal recurring nature. The results of operations for the quarter and nine months ended September 30, 2015 are not necessarily indicative of the results that may be achieved for a full fiscal year and cannot be used to indicate financial performance for the entire year.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2015
SIGNIFICANT ACCOUNTING POLICIES [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	(2) SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation/Basis of Consolidation The accompanying condensed consolidated financial statements have been prepared on the accrual basis of accounting. These financial statements present the financial position and results of operations of the Company and the dental offices (“Offices”), which are under the control of the Company. The Offices are organized as professional corporations (“P.C.s”) and the Company provides business services to the Offices under long-term management agreements (the “Management Agreements”). All intercompany accounts and transactions have been eliminated in the consolidation. The Company treats Offices as consolidated subsidiaries where it has a long-term and unilateral controlling financial interest over the assets and operations of the Offices. The Company maintains control of substantially all of its Offices via the Management Agreements. The Company is a business service organization and does not engage in the practice of dentistry or the provision of dental hygiene services. These services are provided by licensed professionals. Certain key features of these arrangements either enable the Company at any time and in its sole discretion to cause a change in the shareholder of the P.C. (i.e., ''nominee shareholder'') or allow the Company to vote the shares of stock held by the owner of the P.C. and to elect a majority of the board of directors of the P.C. The accompanying condensed consolidated statements of operations reflect revenue, which is the amount billed to patients less contractual adjustments. Direct expenses consist of all the expenses incurred in operating the Offices and paid by the Company. Under the Management Agreements, the Company assumes responsibility for the management of most aspects of the Offices' business (the Company does not engage in the practice of dentistry or the provision of dental hygiene services), including personnel recruitment and training; comprehensive administrative, business and marketing support and advice; and facilities, equipment, and support personnel as required to operate the practices. The Company prepares its consolidated financial statements in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 810, which provides for consolidation of variable interest entities (“VIEs”) of which the Company is the primary beneficiary. The Company has concluded that the P.C.s meet the definition of VIEs as defined by this standard and that the Company is the primary beneficiary of these VIEs. This conclusion was reached because the Company has the power to direct significant activities of the VIEs and the Company is obligated to absorb losses of and/or provide rights to receive benefits from the VIEs. Revenue Revenue is generally recognized when services are provided and is reported at estimated net realizable amounts due from insurance companies, preferred provider and health maintenance organizations (i.e., third-party payors) and patients for services rendered, net of contractual and other adjustments. Dental services are billed and collected by the Company in the name of the Offices. Revenue under certain third-party payor agreements is subject to audit and retroactive adjustments. To the Company’s knowledge, there are no material claims, disputes or other unsettled matters that exist concerning third-party reimbursements as of September 30, 2015. Most of the Company’s patients are insured under third-party payor agreements. The Company’s billing system generates contractual adjustments for each patient encounter based on fee schedules for the patient’s insurance plan. The services provided are attached to the patient’s fee schedule based on the insurance the patient has at the time the service is provided. Therefore, the revenue that is recorded by the billing system is based on insurance contractual amounts. Additionally, each patient at the time of service signs a form agreeing that the patient is ultimately responsible for the contracted fee if the insurance company does not pay the fee for any reason. Note Receivable A note receivable was created as part of a dental Office acquisition, of which approximately $96,000 in principal amount was outstanding at September 30, 2015. The note has equal monthly principal and interest amortization payments and a maturity date of October 31, 2018. The note bears interest at 6%, which is accrued monthly. If the note is uncollectible, an allowance for doubtful accounts will be created. There was no allowance for doubtful accounts for the note as of September 30, 2015 or December 31, 2014. Intangible Assets The Company's dental practice acquisitions involve the purchase of tangible and intangible assets and the assumption of certain liabilities of the acquired dental Offices. As part of the purchase price allocation, the Company allocates the purchase price to the The Management Agreements cannot be terminated by a P.C. without cause, consisting primarily of bankruptcy or material default by the Company. If facts and circumstances indicate that the carrying value of long-lived and intangible assets may be impaired, the Company will perform an evaluation of recoverability. If an evaluation is required, the estimated future undiscounted cash flows associated with the asset will be compared to the asset’s carrying amount to determine if a write-down to market value or discounted cash flow value is required. There were no impairment write-downs associated with the Company’s long-lived and intangible assets during the quarters ended September 30, 2015 and 2014. Stock-Based Compensation Expense The Company recognizes compensation expense on a straight line basis over the requisite service period of the award. Total stock-based compensation expense included in the Company’s condensed consolidated statements of operations for the quarters ended September 30, 2015 and 2014 was approximately $42,000 and $63,000 respectively, related to stock options. Total stock-based compensation expense included in the Company’s condensed consolidated statements of operations for the nine months ended September 30, 2015 and 2014 was approximately $169,000 and $233,000 respectively, related to stock options. Total stock-based compensation expense was recorded as a component of corporate general and administrative expense. The Black-Scholes option-pricing model was used to estimate the option fair values. The option-pricing model requires a number of assumptions, of which the most significant are expected stock price volatility, the expected pre-vesting forfeiture rate, expected dividend rate and the expected option term (the amount of time from the grant date until the options are exercised or expire). Expected volatility was calculated based upon actual historical stock price movements over the most recent periods ended September 30, 2015 equal to the expected option term. Expected pre-vesting forfeitures were estimated based on historical pre-vesting forfeitures over the most recent periods ended September 30, 2015 for the expected option term. Recent Accounting Pronouncements In May 2014, FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). In August 2014, FASB issued ASU No. 2014-15, Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. In January 2015, the FASB issued new accounting guidance eliminating from current accounting guidance the concept of extraordinary items, which, among other things, required an entity to segregate extraordinary items considered to be unusual and infrequent from the results of ordinary operations and show the item separately in the income statement, net of tax, after income from continuing operations. This guidance is effective for public entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted. Adoption of this guidance is not expected to have a significant impact on the Company’s condensed consolidated financial statements. In April 2015, the FASB issued an accounting update simplifying the presentation of debt issuance costs and requiring that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The update did not affect the recognition and measurement guidance for debt issuance costs. This guidance is effective for public entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted. Adoption of this guidance is not expected to have a significant impact on the Company’s condensed consolidated financial statements.

EARNINGS_(LOSS) PER SHARE

EARNINGS/(LOSS) PER SHARE	9 Months Ended
	Sep. 30, 2015
EARNINGS/(LOSS) PER SHARE [Abstract]
EARNINGS/(LOSS) PER SHARE	(3) EARNINGS/(LOSS) PER SHARE The Company calculates earnings/(loss) per share (“EPS”) in accordance with ASC Topic 260. Quarters Ended September 30, 2014 2015 Net Loss Shares Per Share Amount Net Loss Shares Per Share Amount Basic EPS $ (402,688 ) 1,860,089 $ (0.22 ) $ (226,636 ) 1,860,482 $ (0.12 ) Effect of Dilutive Stock Options - - - - - - Diluted EPS $ (402,688 ) 1,860,089 $ (0.22 ) $ (226,636 ) 1,860,482 $ (0.12 ) For the quarters ended September 30, 2015 and 2014, options to purchase 456,148 and 407,343 shares, respectively, of the Company’s common stock (“Common Stock”) were not included in the computation of diluted EPS because their effect was anti-dilutive. Nine Months Ended September 30, 2014 2015 Net Loss Shares Per Share Amount Net Loss Shares Per Share Amount Basic EPS $ (412,596 ) 1,858,232 $ (0.22 ) $ (330,005 ) 1,859,956 $ (0.18 ) Effect of Dilutive Stock Options - - - - - - Diluted EPS $ (412,596 ) 1,858,232 $ (0.22 ) $ (330,005 ) 1,859,956 $ (0.18 ) For the nine months ended September 30, 2015 and 2014, options to purchase 456,491 and 385,263 shares, respectively, of Common Stock were not included in the computation of diluted EPS because their effect was anti-dilutive.

STOCK-BASED COMPENSATION PLANS

STOCK-BASED COMPENSATION PLANS	9 Months Ended
	Sep. 30, 2015
STOCK-BASED COMPENSATION PLANS [Abstract]
STOCK-BASED COMPENSATION PLANS	(4) STOCK-BASED COMPENSATION PLANS The Company’s shareholders approved the 2005 Equity Incentive Plan (as amended, “2005 Plan”) in June 2005. The 2005 Plan terminated on March 17, 2015. The 2005 Plan provided for the grant of incentive stock options, restricted stock, restricted stock units and stock grants to eligible employees (including officers and employee-directors) and non-statutory stock options to eligible employees, directors and consultants. As of September 30, 2015, there were 251,666 vested options and 193,000 unvested options granted under the 2005 Plan that remained outstanding in accordance with their terms and there were no shares available for issuance under the 2005 Plan due to its termination. The Company’s shareholders approved the 2015 Equity Incentive Plan (“2015 Plan”) on June 9, 2015. The 2015 Plan replaces the 2005 Plan. The maximum number of shares of Common Stock that may be delivered to participants and their beneficiaries under the 2015 Plan is 200,000. The 2015 Plan provides for the grant of incentive stock options, stock appreciation right awards, restricted stock awards, stock unit awards and other stock-based awards to eligible recipients. The objectives of the 2015 Plan are to attract and retain the best possible candidates for positions of responsibility and provide for additional performance incentives by providing eligible employees with the opportunity to acquire equity in the Company. The 2015 Plan is administered by a committee of two or more outside directors from the Company’s Board of Directors (the “Committee”). The Committee determines the eligible individuals to whom awards under the 2015 Plan may be granted, as well as the time or times at which awards will be granted, the number of shares subject to awards to be granted to any eligible individual, the term of the award, vesting terms and conditions and any other terms and conditions of the grant in addition to those contained in the 2015 Plan. Each grant under the 2015 Plan will be confirmed by and subject to the terms of an award agreement. The Company uses the Black-Scholes option-pricing model to estimate the fair value of each option granted with the following weighted average assumptions: Quarters Ended September 30, Nine Months Ended September 30, Valuation Assumptions 2014 2015 2014 2015 Expected life (1) 4.00 3.25 4.32 3.25 Risk-free interest rate (2) 1.60 % 1.00 % 1.57 % 1.00 % Expected volatility (3) 34 % 35 % 35 % 35 % Expected dividend yield 5.12 % 6.93 % 5.06 % 6.93 % Expected forfeiture (4) 22.00 % 27.00 % 21.36 % 27.00 % (1) (2) (3) (4) A summary of option activity as of September 30, 2015, and changes during the nine months then ended, is presented below: Number of Options Weighted- Average Exercise Price Range of Exercise Prices Weighted- Average Remaining Contractual Term (years) Aggregate Intrinsic Value (thousands) Outstanding at January 1, 2015 586,833 $ 17.36 $11.50 - $21.00 4.2 $ 197 Granted 11,000 $ 12.69 $12.64 - $12.74 Exercised (6,667 ) $ 11.50 $11.50 - $11.50 Cancelled (135,500 ) $ 18.83 $12.55 - $21.00 Outstanding at September 30, 2015 455,666 $ 16.82 $12.55 - $19.75 4.4 $ 14 Exercisable at September 30, 2015 251,666 $ 18.52 $15.31 - $19.75 3.1 $ - The weighted average grant date fair values of options granted were $1.81 per share and $3.28 per share during the nine months ended September 30, 2015 and 2014, respectively. Net cash proceeds from the exercise of stock options during the nine months ended September 30, 2015 and 2014 were approximately $8,000 and $64,500, respectively. The associated income tax effect from stock options exercised during the nine months ended September 30, 2015 and 2014 was approximately $(5,000) and $11,000, respectively. As of the date of exercise, the total intrinsic value of options exercised during the nine months ended September 30, 2015 and 2014 was approximately $11,000 and $67,000, respectively. As of September 30, 2015, there was approximately $241,000 of total unrecognized compensation expense related to non-vested stock options, which is expected to be recognized over a weighted average period of 2.10 years.

DIVIDENDS

DIVIDENDS	9 Months Ended
	Sep. 30, 2015
DIVIDENDS [Abstract]
DIVIDENDS	(5) DIVIDENDS The Company has declared and paid the following quarterly cash dividends. Date Dividend Paid Quarterly Dividend Paid per Share January 10, 2014; April 11, 2014; July 11, 2014; October 10, 2014 $ 0.22 January 15, 2015; April 17, 2015; July 17, 2015; October 16, 2015 The payment of dividends in the future is subject to the discretion of the Company’s Board of Directors, and various factors may prevent the Company from paying dividends or require the Company to reduce the dividends. Such factors include the Company’s financial position, capital requirements and liquidity, the existence of a stock repurchase program, any loan agreement restrictions, state corporate law restrictions, results of operations and such other factors that the Company’s Board of Directors may consider relevant.

LINE OF CREDIT

LINE OF CREDIT	9 Months Ended
	Sep. 30, 2015
LINE OF CREDIT [Abstract]
LINE OF CREDIT	(6) LINE OF CREDIT On September 13, 2013, the Company entered into a Credit Agreement with Compass Bank, which was amended on February 12, 2014, August 8, 2014 and August 12, 2015 (the “Credit Facility”). The Credit Facility allows the Company to borrow, on a revolving basis, an aggregate principal amount not to exceed $12.0 million. Interest is computed at either the lender’s prime rate or at LIBOR plus 1.40% (increased from 1.15% by the August 12, 2015 amendment) in effect from time to time at the Company’s option. As of September 30, 2015, the Company’s LIBOR borrowing rate was 1.61% and the prime rate borrowing rate was 3.25%. A commitment fee on the average daily unused amount of the revolving loan commitment is also assessed at a rate of 0.25% per annum, and is payable quarterly in arrears. At September 30, 2015, the Company had approximately $10.4 million LIBOR rate borrowings outstanding and approximately $1.6 million available for borrowing under the Credit Facility. The Credit Facility is collateralized by substantially all of the assets of the Company. The Credit Facility requires the Company to comply with certain affirmative and negative covenants, including maintaining (i) a debt-to-EBITDA ratio of no more than 3.00 to 1.00 (increased from 2.05 to 1.00 by the August 12, 2015 amendment) for the year ending December 31, 2015, and 2.50 to 1.00 (increased from 2.00 to 1.00 by the August 12, 2015 amendment) for the twelve months ending June 30, 2016, and (ii) a fixed charge coverage ratio of not less than 1.25 to 1.00. At September 30, 2015, the Company was in compliance with the Credit Facility covenants. The loan matures on September 13, 2016, and as a result the principal amount outstanding is reported in current liabilities on the Company’s condensed consolidated balance sheet as of September 30, 2015. The Company has commenced discussions with Compass Bank to refinance the Credit Facility or extend its maturity date. Failure of the Company to refinance the Credit Facility, extend its maturity date, or obtain other bank financing by September 30, 2016 would have a material adverse effect on the Company.

DISCLOSURES ABOUT FAIR VALUE OF

DISCLOSURES ABOUT FAIR VALUE OF FINANCIAL INSTRUMENTS	9 Months Ended
	Sep. 30, 2015
DISCLOSURES ABOUT FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]
DISCLOSURES ABOUT FAIR VALUE OF FINANCIAL INSTRUMENTS	(7) DISCLOSURES ABOUT FAIR VALUE OF FINANCIAL INSTRUMENTS ASC Topic 825, ''Disclosures About Fair Value of Financial Instruments,'' requires disclosure about the fair value of financial instruments. Carrying amounts for all financial instruments included in current assets and current liabilities approximate estimated fair values due to the short maturity of those instruments. The fair values of the Company's long-term debt are based on similar rates currently available to the Company. The Company believes the book value approximates fair value for the notes receivable. The Company follows ASC Topic 820, “Fair Value Measurements and Disclosures,” which defines fair value, establishes a framework for using fair value to measure assets and liabilities, and expands disclosures about fair value measurements. The statement establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions of what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the reliability of the inputs as follows: Level 1: Quoted prices are available in active markets for identical assets or liabilities. Level 2: Quoted prices in active markets for similar assets and liabilities that are observable for the asset or liability; or Level 3: Unobservable pricing inputs that are generally less observable from objective sources, such as discounted cash flow models or valuations. ASC Topic 820 requires financial assets and liabilities to be classified based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels. There were no transfers between the fair value hierarchy levels during the quarters ended September 30, 2015 and 2014. The following table represents the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2014 and September 30, 2015 by level within the fair value hierarchy: December 31, 2014 Fair Value Measurement Using September 30, 2015 Fair Value Measurement Using Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Contingent Liabilities Balance $ - - $ 421,000 $ - - $ 421,000 Contingent Liabilities As part of an Office acquisition completed in 2009, the Company recorded contingent liabilities to recognize an estimated amount to be paid as part of the acquisition agreement. These contingent liabilities are recorded at estimated fair values as of the date of acquisition, are payable beginning after four years from the acquisition date and are calculated at a multiple of the then trailing twelve-months operating cash flows. The Company remeasures the contingent liability to fair value each reporting date until the contingency is resolved. Any changes to the fair value are recognized into the income statement when determined. As of September 30, 2015, approximately $421,000 of contingent liabilities were recorded on the consolidated balance sheets in other long-term obligations.

SIGNIFICANT ACCOUNTING POLICI15

SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2015
SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Basis of Presentation/Basis of Consolidation	Basis of Presentation/Basis of Consolidation The accompanying condensed consolidated financial statements have been prepared on the accrual basis of accounting. These financial statements present the financial position and results of operations of the Company and the dental offices (“Offices”), which are under the control of the Company. The Offices are organized as professional corporations (“P.C.s”) and the Company provides business services to the Offices under long-term management agreements (the “Management Agreements”). All intercompany accounts and transactions have been eliminated in the consolidation. The Company treats Offices as consolidated subsidiaries where it has a long-term and unilateral controlling financial interest over the assets and operations of the Offices. The Company maintains control of substantially all of its Offices via the Management Agreements. The Company is a business service organization and does not engage in the practice of dentistry or the provision of dental hygiene services. These services are provided by licensed professionals. Certain key features of these arrangements either enable the Company at any time and in its sole discretion to cause a change in the shareholder of the P.C. (i.e., ''nominee shareholder'') or allow the Company to vote the shares of stock held by the owner of the P.C. and to elect a majority of the board of directors of the P.C. The accompanying condensed consolidated statements of operations reflect revenue, which is the amount billed to patients less contractual adjustments. Direct expenses consist of all the expenses incurred in operating the Offices and paid by the Company. Under the Management Agreements, the Company assumes responsibility for the management of most aspects of the Offices' business (the Company does not engage in the practice of dentistry or the provision of dental hygiene services), including personnel recruitment and training; comprehensive administrative, business and marketing support and advice; and facilities, equipment, and support personnel as required to operate the practices. The Company prepares its consolidated financial statements in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 810, which provides for consolidation of variable interest entities (“VIEs”) of which the Company is the primary beneficiary. The Company has concluded that the P.C.s meet the definition of VIEs as defined by this standard and that the Company is the primary beneficiary of these VIEs. This conclusion was reached because the Company has the power to direct significant activities of the VIEs and the Company is obligated to absorb losses of and/or provide rights to receive benefits from the VIEs.
Revenue	Revenue Revenue is generally recognized when services are provided and is reported at estimated net realizable amounts due from insurance companies, preferred provider and health maintenance organizations (i.e., third-party payors) and patients for services rendered, net of contractual and other adjustments. Dental services are billed and collected by the Company in the name of the Offices. Revenue under certain third-party payor agreements is subject to audit and retroactive adjustments. To the Company’s knowledge, there are no material claims, disputes or other unsettled matters that exist concerning third-party reimbursements as of September 30, 2015. Most of the Company’s patients are insured under third-party payor agreements. The Company’s billing system generates contractual adjustments for each patient encounter based on fee schedules for the patient’s insurance plan. The services provided are attached to the patient’s fee schedule based on the insurance the patient has at the time the service is provided. Therefore, the revenue that is recorded by the billing system is based on insurance contractual amounts. Additionally, each patient at the time of service signs a form agreeing that the patient is ultimately responsible for the contracted fee if the insurance company does not pay the fee for any reason.
Note Receivable	Note Receivable A note receivable was created as part of a dental Office acquisition, of which approximately $96,000 in principal amount was outstanding at September 30, 2015. The note has equal monthly principal and interest amortization payments and a maturity date of October 31, 2018. The note bears interest at 6%, which is accrued monthly. If the note is uncollectible, an allowance for doubtful accounts will be created. There was no allowance for doubtful accounts for the note as of September 30, 2015 or December 31, 2014.
Intangible Assets	Intangible Assets The Company's dental practice acquisitions involve the purchase of tangible and intangible assets and the assumption of certain liabilities of the acquired dental Offices. As part of the purchase price allocation, the Company allocates the purchase price to the The Management Agreements cannot be terminated by a P.C. without cause, consisting primarily of bankruptcy or material default by the Company. If facts and circumstances indicate that the carrying value of long-lived and intangible assets may be impaired, the Company will perform an evaluation of recoverability. If an evaluation is required, the estimated future undiscounted cash flows associated with the asset will be compared to the asset’s carrying amount to determine if a write-down to market value or discounted cash flow value is required. There were no impairment write-downs associated with the Company’s long-lived and intangible assets during the quarters ended September 30, 2015 and 2014.
Stock-Based Compensation Expense	Stock-Based Compensation Expense The Company recognizes compensation expense on a straight line basis over the requisite service period of the award. Total stock-based compensation expense included in the Company’s condensed consolidated statements of operations for the quarters ended September 30, 2015 and 2014 was approximately $42,000 and $63,000 respectively, related to stock options. Total stock-based compensation expense included in the Company’s condensed consolidated statements of operations for the nine months ended September 30, 2015 and 2014 was approximately $169,000 and $233,000 respectively, related to stock options. Total stock-based compensation expense was recorded as a component of corporate general and administrative expense. The Black-Scholes option-pricing model was used to estimate the option fair values. The option-pricing model requires a number of assumptions, of which the most significant are expected stock price volatility, the expected pre-vesting forfeiture rate, expected dividend rate and the expected option term (the amount of time from the grant date until the options are exercised or expire). Expected volatility was calculated based upon actual historical stock price movements over the most recent periods ended September 30, 2015 equal to the expected option term. Expected pre-vesting forfeitures were estimated based on historical pre-vesting forfeitures over the most recent periods ended September 30, 2015 for the expected option term.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In May 2014, FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). In August 2014, FASB issued ASU No. 2014-15, Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. In January 2015, the FASB issued new accounting guidance eliminating from current accounting guidance the concept of extraordinary items, which, among other things, required an entity to segregate extraordinary items considered to be unusual and infrequent from the results of ordinary operations and show the item separately in the income statement, net of tax, after income from continuing operations. This guidance is effective for public entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted. Adoption of this guidance is not expected to have a significant impact on the Company’s condensed consolidated financial statements. In April 2015, the FASB issued an accounting update simplifying the presentation of debt issuance costs and requiring that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The update did not affect the recognition and measurement guidance for debt issuance costs. This guidance is effective for public entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted. Adoption of this guidance is not expected to have a significant impact on the Company’s condensed consolidated financial statements.

EARNINGS_(LOSS) PER SHARE (Tabl

EARNINGS/(LOSS) PER SHARE (Tables)	9 Months Ended
	Sep. 30, 2015
EARNINGS/(LOSS) PER SHARE [Abstract]
Earnings/(loss) per share calculation	The Company calculates earnings/(loss) per share (“EPS”) in accordance with ASC Topic 260. Quarters Ended September 30, 2014 2015 Net Loss Shares Per Share Amount Net Loss Shares Per Share Amount Basic EPS $ (402,688 ) 1,860,089 $ (0.22 ) $ (226,636 ) 1,860,482 $ (0.12 ) Effect of Dilutive Stock Options - - - - - - Diluted EPS $ (402,688 ) 1,860,089 $ (0.22 ) $ (226,636 ) 1,860,482 $ (0.12 ) For the quarters ended September 30, 2015 and 2014, options to purchase 456,148 and 407,343 shares, respectively, of the Company’s common stock (“Common Stock”) were not included in the computation of diluted EPS because their effect was anti-dilutive. Nine Months Ended September 30, 2014 2015 Net Loss Shares Per Share Amount Net Loss Shares Per Share Amount Basic EPS $ (412,596 ) 1,858,232 $ (0.22 ) $ (330,005 ) 1,859,956 $ (0.18 ) Effect of Dilutive Stock Options - - - - - - Diluted EPS $ (412,596 ) 1,858,232 $ (0.22 ) $ (330,005 ) 1,859,956 $ (0.18 )

STOCK-BASED COMPENSATION PLANS

STOCK-BASED COMPENSATION PLANS (Tables)	9 Months Ended
	Sep. 30, 2015
STOCK-BASED COMPENSATION PLANS [Abstract]
Options valuation assumptions	The Company uses the Black-Scholes option-pricing model to estimate the fair value of each option granted with the following weighted average assumptions: Quarters Ended September 30, Nine Months Ended September 30, Valuation Assumptions 2014 2015 2014 2015 Expected life (1) 4.00 3.25 4.32 3.25 Risk-free interest rate (2) 1.60 % 1.00 % 1.57 % 1.00 % Expected volatility (3) 34 % 35 % 35 % 35 % Expected dividend yield 5.12 % 6.93 % 5.06 % 6.93 % Expected forfeiture (4) 22.00 % 27.00 % 21.36 % 27.00 % (1) (2) (3) (4)
Summary of option activity	A summary of option activity as of September 30, 2015, and changes during the nine months then ended, is presented below: Number of Options Weighted- Average Exercise Price Range of Exercise Prices Weighted- Average Remaining Contractual Term (years) Aggregate Intrinsic Value (thousands) Outstanding at January 1, 2015 586,833 $ 17.36 $11.50 - $21.00 4.2 $ 197 Granted 11,000 $ 12.69 $12.64 - $12.74 Exercised (6,667 ) $ 11.50 $11.50 - $11.50 Cancelled (135,500 ) $ 18.83 $12.55 - $21.00 Outstanding at September 30, 2015 455,666 $ 16.82 $12.55 - $19.75 4.4 $ 14 Exercisable at September 30, 2015 251,666 $ 18.52 $15.31 - $19.75 3.1 $ -

DIVIDENDS (Tables)

DIVIDENDS (Tables)	9 Months Ended
	Sep. 30, 2015
DIVIDENDS [Abstract]
Dividends payable	The Company has declared and paid the following quarterly cash dividends. Date Dividend Paid Quarterly Dividend Paid per Share January 10, 2014; April 11, 2014; July 11, 2014; October 10, 2014 $ 0.22 January 15, 2015; April 17, 2015; July 17, 2015; October 16, 2015

DISCLOSURES ABOUT FAIR VALUE 19

DISCLOSURES ABOUT FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)	9 Months Ended
	Sep. 30, 2015
DISCLOSURES ABOUT FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]
Fair value, assets and liabilities measured on recurring basis	The following table represents the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2014 and September 30, 2015 by level within the fair value hierarchy: December 31, 2014 Fair Value Measurement Using September 30, 2015 Fair Value Measurement Using Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Contingent Liabilities Balance $ - - $ 421,000 $ - - $ 421,000

SIGNIFICANT ACCOUNTING POLICI20

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Note Receivable [Abstract]
Outstanding principal amount of note receivables	$ 96,000		$ 96,000
Maturity date			Oct. 31, 2018
Interest rate on notes receivable			6.00%
Allowance for doubtful accounts	0		$ 0		$ 0
Intangible Assets [Abstract]
Life of the management agreement			40 years
Amortization period for contract			25 years
Amortization expense	211,000	$ 221,000	$ 634,000	$ 671,000
Impairment of Long-Lived and Intangible Assets [Abstract]
Impairment of long-lived and intangible assets	0	0
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense	$ 42,000	$ 63,000	$ 169,000	$ 233,000

EARNINGS_(LOSS) PER SHARE (Deta

EARNINGS/(LOSS) PER SHARE (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Net income/(loss), diluted [Abstract]
Net loss, basic EPS	$ (226,636)	$ (402,688)	$ (330,005)	$ (412,596)
Effect of dilutive stock options	0	0	0	0
Net loss, diluted EPS	$ (226,636)	$ (402,688)	$ (330,005)	$ (412,596)
Weighted average number of shares outstanding reconciliation [Abstract]
Weighted average number of shares, basic EPS (in shares)	1,860,482	1,860,089	1,859,956	1,858,232
Effect of dilutive stock options, shares (in shares)	0	0	0	0
Weighted average number of shares outstanding, diluted EPS (in shares)	1,860,482	1,860,089	1,859,956	1,858,232
Earnings per share, basic and diluted [Abstract]
Earnings per share, basic EPS (in dollars per share)	$ (0.12)	$ (0.22)	$ (0.18)	$ (0.22)
Effect of dilutive stock option (in dollars per share)	0	0	0	0
Per share amount - diluted EPS (in dollars per share)	$ (0.12)	$ (0.22)	$ (0.18)	$ (0.22)
Antidilutive securities (in shares)	456,148	407,343	456,491	385,263

STOCK-BASED COMPENSATION PLAN22

STOCK-BASED COMPENSATION PLANS (Details) - Stock Options [Member]		3 Months Ended		9 Months Ended		12 Months Ended
		Sep. 30, 2015USD ($)Administrator$ / sharesshares	Sep. 30, 2014	Sep. 30, 2015USD ($)Administrator$ / sharesshares	Sep. 30, 2014USD ($)$ / shares	Dec. 31, 2014USD ($)$ / sharesshares
Fair value assumptions [Abstract]
Expected life	[1]	3 years 3 months	4 years	3 years 3 months	4 years 3 months 25 days
Risk-free interest rate	[2]	1.00%	1.60%	1.00%	1.57%
Expected volatility	[3]	35.00%	34.00%	35.00%	35.00%
Expected dividend yield		6.93%	5.12%	6.93%	5.06%
Expected forfeiture	[4]	27.00%	22.00%	27.00%	21.36%
Options outstanding [Rollforward]
Outstanding, beginning balance (in shares) | shares				586,833
Granted (in shares) | shares				11,000
Exercised (in shares) | shares				(6,667)
Cancelled (in shares) | shares				(135,500)
Outstanding, ending balance (in shares) | shares		455,666		455,666		586,833
Exercisable (in shares) | shares		251,666		251,666
Options weighted average exercise price [Roll Forward]
Outstanding, beginning balance (in dollars per share)				$ 17.36
Granted (in dollars per share)				12.69
Exercised (in dollars per share)				11.50
Cancelled (in dollars per share)				18.83
Outstanding, ending balance (in dollars per share)		$ 16.82		16.82		$ 17.36
Exercisable (in dollars per share)		$ 18.52		$ 18.52
Options, additional disclosures [Abstract]
Outstanding, weighted average remaining contractual term				4 years 4 months 24 days		4 years 2 months 12 days
Outstanding, aggregate intrinsic value | $		$ 14,000		$ 14,000		$ 197,000
Exercisable, weighted average remaining contractual term				3 years 1 month 6 days
Exercisable, aggregate intrinsic value | $		0		$ 0
Total unrecognized compensation expense | $		$ 241,000		$ 241,000
Weighted average period for recognition				2 years 1 month 6 days
Minimum [Member]
Range of Exercise Prices [Abstract]
Outstanding, beginning of period (in dollars per share)				$ 11.50
Granted (in dollars per share)				12.64
Exercised (in dollars per share)				11.50
Cancelled (in dollars per share)				12.55
Outstanding, end of period (in dollars per share)		$ 12.55		12.55		$ 11.50
Exercisable (in dollars per share)		15.31		15.31
Maximum [Member]
Range of Exercise Prices [Abstract]
Outstanding, beginning of period (in dollars per share)				21
Granted (in dollars per share)				12.74
Exercised (in dollars per share)				11.50
Cancelled (in dollars per share)				21
Outstanding, end of period (in dollars per share)		19.75		19.75		$ 21
Exercisable (in dollars per share)		$ 19.75		$ 19.75
2005 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for issuance (in shares) | shares		0		0
Vested options (in shares) | shares		251,666		251,666
Unvested options (in shares) | shares		193,000		193,000
Options, additional disclosures [Abstract]
Weighted average grant date fair value of options (in dollars per share)					$ 3.28
Net cash proceeds from the exercise of stock options | $					$ 64,500
Income tax effect | $					11,000
Intrinsic value | $					$ 67,000
2015 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for issuance (in shares) | shares		189,000		189,000
Minimum number of plan administrators | Administrator		2		2
Unvested options (in shares) | shares		11,000		11,000
Maximum number of shares of Common Stock that can be delivered under the plan (in shares) | shares		200,000		200,000
Options, additional disclosures [Abstract]
Weighted average grant date fair value of options (in dollars per share)				$ 1.81
Net cash proceeds from the exercise of stock options | $				$ 8,000
Income tax effect | $				(5,000)
Intrinsic value | $				$ 11,000
[1]	The expected life, in years, of stock options is estimated based on historical experience.
[2]	The risk-free interest rate is based on U.S. Treasury bills whose term is consistent with the expected life of the stock options.
[3]	The expected volatility is estimated based on historical and current stock price data for the Company.
[4]	Forfeitures are estimated based on historical experience.

DIVIDENDS (Details)

DIVIDENDS (Details) - $ / shares	3 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013
DIVIDENDS [Abstract]
Quarterly Dividend Paid per Share (in dollars per share)	$ 0.22	$ 0.22	$ 0.22	$ 0.22	$ 0.22	$ 0.22	$ 0.22	$ 0.22
Date Dividend Paid	Oct. 16, 2015	Jul. 17, 2015	Apr. 17, 2015	Jan. 15, 2015	Oct. 10, 2014	Jul. 11, 2014	Apr. 11, 2014	Jan. 10, 2014

LINE OF CREDIT (Details)

LINE OF CREDIT (Details) - Line of Credit [Member] - USD ($) $ in Millions	2 Months Ended	7 Months Ended	9 Months Ended
	Sep. 30, 2015	Aug. 11, 2015	Sep. 30, 2015	Sep. 13, 2013
Long-term Debt [Line Items]
Maximum borrowing capacity				$ 12
Commitment fee percentage			0.25%
Amount outstanding	$ 1.6		$ 1.6
Maturity date			Sep. 13, 2016
Debt To EBITDA ratio for the year ending December 31, 2015	3	2.05
Debt To EBITDA ratio for the twelve months ending June 30, 2016	2.50	2
Fixed charge coverage ratio			1.25
LIBOR Borrowing Rate [Member]
Long-term Debt [Line Items]
Basis spread on variable rate	1.40%	1.15%
Borrowing rate	1.61%		1.61%
Amount outstanding	$ 10.4		$ 10.4
Base Rate Option [Member]
Long-term Debt [Line Items]
Borrowing rate	3.25%		3.25%

DISCLOSURES ABOUT FAIR VALUE 25

DISCLOSURES ABOUT FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - USD ($)	9 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Contingent Liabilities [Abstract]
Number of years until the contingent liability becomes payable	4 years
Number of trailing months of operating cash flow used to determine contingent liability	12 months
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Liabilities, Fair Value Disclosure [Abstract]
Contingent Liabilities Balance	$ 0	$ 0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Liabilities, Fair Value Disclosure [Abstract]
Contingent Liabilities Balance	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Liabilities, Fair Value Disclosure [Abstract]
Contingent Liabilities Balance	$ 421,000	$ 421,000